Print

ATLAS Biolabs GmbH Achieves Roche NimbleGen, Inc Certification for Solution-Based SeqCap EZ Enrichment  
3/29/2011 9:35:00 AM

MADISON, Wis.--(BUSINESS WIRE)--Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) announces that ATLAS Biolabs GmbH, located in Berlin, Germany, has passed the certification process to qualify as a Roche NimbleGen Certified Service Provider (CSP) for SeqCap EZ enrichment.
//-->